Characterization of WNT7A expression in human endometrium and endometriotic lesions

Fertility and Sterility

Volumn 88, Issue 6, 2007, Pages 1534-1540

  Gaetje, Regine ^a   Holtrich, Uwe ^a   Karn, Thomas ^a   Cikrit, Eva ^a   Engels, Knut ^a   Rody, Achim ^a   Kaufmann, Manfred ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

endometriosis; endometrium; WNT wingless type MMTV integration site family

Indexed keywords

PROTEIN; PROTEIN WNT7A; UNCLASSIFIED DRUG;

ARTICLE; ECTOPIC ENDOMETRIUM; ENDOMETRIAL DISEASE; ENDOMETRIOSIS; ENDOMETRIUM; EUTOPIC ENDOMETRIUM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IN SITU HYBRIDIZATION; LASER MICRODISSECTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; TREATMENT INDICATION;

ADULT; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MICRODISSECTION; MIDDLE AGED; PERITONEAL DISEASES; POLYMERASE CHAIN REACTION; RNA, MESSENGER; WNT PROTEINS;

EID: 36749000598     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.01.128     Document Type: Article

References (15)

1. Parr B.A., and McMahon A.P. Sexually dimorphic development of the mammalian reproductive tract requires WNT-7A. Nature 395 (1998) 707-710
2. Miller C., and Sassoon D.A. Wnt7a maintains appropriate uterine patterning during the development of the mouse female reproductive tract. Development 125 (1998) 3201-3211
3. Tulac S., Nayak N.R., Kao L.C., van Waes M., Huang J., Lobo S., et al. Identification, characterization, and regulation of the canonical Wnt signaling pathway in human endometrium. J Clin Endocrinol Metab 88 (2003) 3860-3966
4. Gaetje R, Holtrich U, Engels K, Kissler S, Rody A, Karn T, Kaufmann M. Endometriosis may be generated by mimicking the ontogenetic development of the female genital tract. Fertil Steril; Nov 28: [epub ahead of print].
5. Hayashi K., and Spencer T.E. WNT pathways in the neonatal ovine uterus: potential specification of endometrial gland morphogenesis by SFRP2. Biol Reprod 74 (2006) 721-733
6. Miller C., Degenhardt K., and Sassoon D. Fetal exposure to DES results in de-regulation of Wnt7a during uterine morphogenesis. Nat Genet 20 (1998) 228-230
7. Wagner J., and Lehmann L. Estrogen modulate the gene expression of Wnt-7a in cultured endometrial adenocarcinoma cells. Mol Nutr Food Res 50 (2006) 368-372
8. Oehler M.K., MacKenzie I.Z., Wallwiener D., Bicknell R., and Ress M.C. Wnt-7a is upregulated by norethisterone in human endometrial epithelial cells: a possible mechanism by which progesterons reduce the risk of estrogen-induced endometrial neoplasia. Cancer Lett 186 (2002) 75-81
9. Tulac S., Overgaard M.T., Hamilton A.E., Jumbe N.L., Suchanek E., and Giudice L.C. Dickkopf-1, an inhibitor of Wnt signaling, is reduced by progesterone in human endometrial stromal cells. J Clin Endocrinol Metab 91 (2006) 1453-1461
10. Holtrich U., Wolf G., Brauninger A., Karn T., Bohme B., Rubsamen-Waigmann H., and Strebhardt K. Induction and down-regulation of PLK, a human serine/threonine kinase expressed in proliferating cells and tumors. Proc Natl Acad Sci USA 91 (1994) 1736-1740
11. Ahr A., Holtrich U., Solbach C., Scharl A., Strebhardt K., Karn T., and Kaufmann M. Molecular classification of breast cancer patients by gene expression profiling. J Pathol 195 (2001) 312-320
12. Basyuk E., Bertrand E., and Journot L. Alkaline fixation drastically improves the signal of in situ hybridization. Nucleic Acids Res 28 (2000) E46
13. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 67 (1997) 817-821
14. Bui T.D., Zhang L., Ress M.C., Bicknell R., and Harris A.L. Expression and hormone regulation of Wnt2, 3, 4, 5a, 7a, 7b and 10b in normal human endometrium and endometrial carcinoma. Br J Cancer 75 (1997) 1131-1136
15. Mericskay M., Kitajewski J., and Sassoon D. WNT5A is required for proper epithelial-mesenchymal interactions in the uterus. Development 131 (2004) 2061-2072